2.4. Sample Size Calculation
The sample size required to evaluate the superiority of combination therapy over celecoxib monotherapy was calculated via the equation below, using the following conditions: ZA sample size of 63 patients per group was determined using the above formula. Subsequently, considering a dropout rate of 10%, a final sample size of 70 patients per group was obtained.